ACADIA Pharmaceuticals
ACAD
#3212
Rank
A$6.90 B
Marketcap
A$40.80
Share price
1.76%
Change (1 day)
50.69%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2025 (TTM): A$0.43 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are A$1.04 Billion. In 2024 the company made an earning of A$0.38 Billion, an increase over its 2023 earnings that were of -A$76.7 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$0.43 B11.41%
2024 A$0.38 B-605.67%
2023 -A$76.7 Million-76.09%
2022 -A$0.33 Billion27.41%
2021 -A$0.26 Billion-40.38%
2020 -A$0.43 Billion19.88%
2019 -A$0.36 Billion-3.92%
2018 -A$0.37 Billion-15.04%
2017 -A$0.44 Billion6.33%
2016 -A$0.41 Billion64.55%
2015 -A$0.25 Billion77.47%
2014 -A$0.14 Billion143.69%
2013 -A$57.03 Million81.93%
2012 -A$31.35 Million-8.73%
2011 -A$34.34 Million-251.39%
2010 A$22.68 M-133.2%
2009 -A$68.33 Million-30.82%
2008 -A$98.77 Million6.43%
2007 -A$92.8 Million25.89%
2006 -A$73.72 Million36.99%
2005 -A$53.81 Million37.22%
2004 -A$39.22 Million19.96%
2003 -A$32.69 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Vanda Pharmaceuticals
VNDA
-A$0.19 Billion-144.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$17.81 B 4,230.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$33.81 B 8,122.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$48.68 B 11,737.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$12.07 B 2,835.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
-A$58.05 Million-114.12%๐Ÿ‡บ๐Ÿ‡ธ USA